Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
Más filtros












Intervalo de año de publicación
1.
Microb Pathog ; 194: 106833, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-39096943

RESUMEN

Bacterial biofilms pose a significant threat to healthcare due to their recalcitrance to antibiotics and disinfectants. This study explores the anti-biofilm potential of Bacillus licheniformis cell-free culture supernatant (CFS) and its derived silver nanoparticles (bSNPs) against Staphylococcus aureus and Pseudomonas aeruginosa. The CFS exhibited potent anti-biofilm activity against both bacterial species, even at low concentrations, while devoid of significant bactericidal effects, mitigating resistance risks. Characterization studies revealed the non-proteinaceous nature and thermal stability of the CFS's anti-biofilm agent, suggesting a robust and heat-resistant structure. Green synthesis of bSNPs from CFS resulted in nanoparticles with significant anti-biofilm properties, particularly against P. aeruginosa, indicating differences in susceptibility between the bacterial species. Epifluorescence microscopy confirmed bSNPs' ability to inhibit and partially disrupt biofilm formation without inducing cellular lysis. The study highlights the potential of B. licheniformis CFS and bSNPs as promising biofilm control agents, offering insights into their mechanisms of action and broad-spectrum efficacy. Further research elucidating the underlying molecular mechanisms and identifying specific bioactive compounds is warranted for the translation of these findings into clinically relevant applications for combating biofilm-associated infections.


Asunto(s)
Antibacterianos , Bacillus licheniformis , Biopelículas , Nanopartículas del Metal , Pruebas de Sensibilidad Microbiana , Pseudomonas aeruginosa , Plata , Staphylococcus aureus , Biopelículas/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Plata/farmacología , Plata/química , Nanopartículas del Metal/química , Pseudomonas aeruginosa/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Bacillus licheniformis/metabolismo , Bacillus licheniformis/efectos de los fármacos , Antibacterianos/farmacología , Antibacterianos/química
2.
Medicine (Baltimore) ; 101(4): e28719, 2022 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-35089241

RESUMEN

RATIONALE: Bacillus licheniformis (B licheniformis) is a commonly used microbiota modulator. However, infections are rarely observed in immunocompetent hosts. PATIENT CONCERNS: A 67-year-old woman who underwent esophagectomy experienced accidental injection of B licheniformis and presented with chills followed by hyperpyrexia. DIAGNOSIS: The initial diagnosis was B licheniformis bacteremia. INTERVENTION: Based on our experience, the patient first received levofloxacin and ornidazole. The application of levofloxacin was retained based on the antibiogram results. After discharge, the antibiotics were changed to vancomycin and levofloxacin, based on sensitivity tests, until two consecutive blood cultures were negative. OUTCOMES: The patient recovered without any severe complications. LESSONS: This is a rare report of the successful treatment of B licheniformis bacteremia caused by improper drug administration, which will provide a reference for the treatment of B licheniformis bacteremia.


Asunto(s)
Infecciones por Bacillaceae/tratamiento farmacológico , Bacillus licheniformis/aislamiento & purificación , Bacteriemia/tratamiento farmacológico , Catéteres Venosos Centrales/microbiología , Anciano , Antibacterianos/uso terapéutico , Infecciones por Bacillaceae/diagnóstico , Bacillus licheniformis/efectos de los fármacos , Bacteriemia/diagnóstico , Femenino , Humanos , Levofloxacino/uso terapéutico , Errores Médicos , Microbiota , Vancomicina/uso terapéutico
3.
J Oleo Sci ; 71(2): 257-265, 2022 Feb 03.
Artículo en Inglés | MEDLINE | ID: mdl-35034942

RESUMEN

Biogenic synthesis of silver nanoparticles (AgNPs) is more eco-friendly and cost-effective approach as compared to the conventional chemical synthesis. Biologically synthesized AgNPs have been proved as therapeutically effective and valuable compounds. In this study, the four bacterial strains Escherichia coli (MT448673), Pseudomonas aeruginosa (MN900691), Bacillus subtilis (MN900684) and Bacillus licheniformis (MN900686) were used for the biogenic synthesis of AgNPs. Agar well diffusion assay revealed to determine the antibacterial activity of all biogenically synthesized AGNPs showed that P. aeruginosa AgNPs possessed significantly high (p < 0.05) antibacterial potential against all tested isolates. The one-way ANOVA test showed that that P. aeruginosa AgNPs showed significantly (p < 0.05) larger zones of inhibition (ZOI: 19 to 22 mm) compared to the positive control (rifampicin: 50 µg/mL) while no ZOI was observed against negative control (Dimethyl sulfoxide: DMSO). Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) concentration against four test strains also showed that among all biogenically synthesized NPs, P. aeruginosa AgNPs showed effective MIC (3.3-3.6 µg/mL) and MBC (4.3-4.6 µg/mL). Hence, P. aeruginosa AGNPs were characterized using visual UV vis-spectroscopy, X-ray diffractometer (XRD), fourier transform infrared (FTIR) and scanning electron microscopy (SEM). The formation of peak around 430 nm indicated the formation of AgNPs while the FTIR confirmed the involvement of biological molecules in the formation of nanoparticles (NPs). SEM revealed that the NPs were of approximately 40 nm. Overall, this study suggested that the biogenically synthesized nanoparticles could be utilized as effective antimicrobial agents for effective disease control.


Asunto(s)
Antibacterianos , Nanopartículas del Metal/química , Compuestos de Plata/síntesis química , Compuestos de Plata/farmacología , Agar , Bacillus licheniformis/efectos de los fármacos , Bacillus subtilis/efectos de los fármacos , Análisis Costo-Beneficio , Evaluación Preclínica de Medicamentos/métodos , Farmacorresistencia Bacteriana , Escherichia coli/efectos de los fármacos , Microscopía Electrónica de Rastreo , Microscopía Electrónica de Transmisión , Pseudomonas aeruginosa/efectos de los fármacos , Compuestos de Plata/química , Difracción de Rayos X
4.
Pak J Pharm Sci ; 34(3(Special)): 1271-1276, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-34602399

RESUMEN

The research on bioactive secondary metabolites from Aspergillus fumigatus afforded six compounds, which were identified by mass spectrometer (MS) and nuclear magnetic resonance (NMR) spectroscopic analysis as cyclopyazonic acid (1), trypacidin A (2), asterric acid (3), methyl asterrate (4), demethylcitreoviranol (5), as well as (5-hydroxy-2-oxo-2H-pyran-4-yl) methyl acetate (6). Cyclopyazonic acid (1) was found to have potent antibacterial effects, especially against Bacillus licheniformis with minimal inhibitory concentration (MIC) value of 3.7µg/mL. Its antibacterial effects were possibly related to the olefinic acid group in the structure. Phenyl ether derivatives 3 and 4, and trypacidin A (2) also exhibited antimicrobial effects. In addition, compound 6 showed significant antioxidant effects with half maximal effective concentration (EC50) value of 10.2µM in the ABTS (2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid) assay, which was better than the positive control.


Asunto(s)
Antibacterianos/farmacología , Antioxidantes/farmacología , Aspergillus fumigatus/metabolismo , Acetatos/química , Acetatos/farmacología , Animales , Aspergillus fumigatus/química , Bacillus/efectos de los fármacos , Bacillus licheniformis/efectos de los fármacos , Bacillus subtilis/efectos de los fármacos , Espectroscopía de Resonancia Magnética con Carbono-13 , Escherichia coli/efectos de los fármacos , Indoles/química , Indoles/farmacología , Insectos , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Pruebas de Sensibilidad Microbiana , Micotoxinas/farmacología , Fenoles/química , Fenoles/farmacología , Éteres Fenílicos/química , Éteres Fenílicos/farmacología , Espectroscopía de Protones por Resonancia Magnética , Pseudomonas aeruginosa/efectos de los fármacos , Piranos/química , Piranos/farmacología , Staphylococcus aureus/efectos de los fármacos
5.
Int J Biol Macromol ; 163: 2306-2313, 2020 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-32941899

RESUMEN

In this study soluble soybean polysaccharide­iron(III) (SSPS-Fe(III)) was synthesized to investigate the effects on the growth of Escherichia coli, Staphylococcus aureus and Bacillus licheniformis. Two new detection methods of real-time fluorescence quantitative polymerase chain reaction (qRT-PCR) and microcalorimetry were used to evaluate the effects of different concentrations of SSPS-Fe(III) on the growth of three bacteria. The copy numbers of three bacteria showed that SSPS-Fe(III) had different impacts on the growth of E. coli, S. aureus and B. licheniformis. E. coli growth was inhibited by SSPS-Fe(III) in the higher concentration range and S. aureus growth was inhibited at any concentration, however B. licheniformis growth was promoted. The thermogenic curves for growth metabolism of E. coli and S. aureus presented peak shapes while those of B. licheniformis did platform shapes. As SSPS-Fe(III) concentration increased, the peak heights lowered for E. coli and S. aureus, and the time reaching stationary phase advanced for B. licheniformis. These findings demonstrate that SSPS-Fe(III) has an inhibitory effect on the foodborne pathogens of E. coli and S. aureus, and an enhancement on the probiotics of B. licheniformis.


Asunto(s)
Complejos de Coordinación/química , Compuestos Férricos/farmacología , Glycine max/química , Polisacáridos/química , Antibacterianos/química , Antibacterianos/farmacología , Bacillus licheniformis/efectos de los fármacos , Complejos de Coordinación/farmacología , Escherichia coli/efectos de los fármacos , Compuestos Férricos/química , Hierro/química , Polisacáridos/farmacología , Probióticos/química , Probióticos/farmacología , Staphylococcus aureus/efectos de los fármacos
6.
PLoS One ; 15(4): e0231274, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32271828

RESUMEN

We evaluated the minimum inhibitory concentrations of clindamycin and erythromycin toward 98 Bacillus licheniformis strains isolated from several types of fermented soybean foods manufactured in several districts of Korea. First, based on recent taxonomic standards for bacteria, the 98 strains were separated into 74 B. licheniformis strains and 24 B. paralicheniformis strains. Both species exhibited profiles of erythromycin resistance as an acquired characteristic. B. licheniformis strains exhibited acquired clindamycin resistance, while B. paralicheniformis strains showed unimodal clindamycin resistance, indicating an intrinsic characteristic. Comparative genomic analysis of five strains showing three different patterns of clindamycin and erythromycin resistance identified 23S rRNA (adenine 2058-N6)-dimethyltransferase gene ermC and spermidine acetyltransferase gene speG as candidates potentially involved in clindamycin resistance. Functional analysis of these genes using B. subtilis as a host showed that ermC contributes to cross-resistance to clindamycin and erythromycin, and speG confers resistance to clindamycin. ermC is located in the chromosomes of strains showing clindamycin and erythromycin resistance and no transposable element was identified in its flanking regions. The acquisition of ermC might be attributable to a homologous recombination. speG was identified in not only the five genome-analyzed strains but also eight strains randomly selected from the 98 test strains, and deletions in the structural gene or putative promoter region caused clindamycin sensitivity, which supports the finding that the clindamycin resistance of Bacillus species is an intrinsic property.


Asunto(s)
Bacillus licheniformis/genética , Bacillus/genética , Clindamicina/farmacología , Farmacorresistencia Bacteriana/genética , Genes Bacterianos , Genómica , Bacillus/efectos de los fármacos , Bacillus/crecimiento & desarrollo , Bacillus licheniformis/clasificación , Bacillus licheniformis/efectos de los fármacos , Bacillus licheniformis/crecimiento & desarrollo , Bacillus subtilis/efectos de los fármacos , Bacillus subtilis/genética , Bacillus subtilis/crecimiento & desarrollo , Secuencia de Bases , Farmacorresistencia Bacteriana/efectos de los fármacos , Eritromicina/farmacología , Pruebas de Sensibilidad Microbiana
7.
Microb Pathog ; 141: 103977, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31953226

RESUMEN

Bacillus licheniformis, a pathogenic new strain of bacteria is considered as the main cause of high mortalities and economic losses among the ornamental fish farms of India. The present study aimed to investigate the anti-bacterial and Immunostimulant activity of three selected Indian medicinal plants, Allium sativum, Adhatoda vasica and Centella asiatica for treating Bacillus licheniformis PKBMS16 by subsequent experimental and clinical trials using different organic polar and non-polar solvents. The antimicrobial and Immunostimulant activity of methanolic crude extracts of Adhatoda vasica was fractions and active constituents was further characterized by chromatography and mass spectroscopy studies using FTIR, 1HNMR and 13c NMR to identify as well as to determine the nature of the pure compound which is phytol (C20H40O), a diterpene alcohol with a molecular weight of m/z 297. In order to study the in vivo anti-pathogenic influence of the biologically active compounds, phytol were incorporated to the artificial diets at the concentration of 2, 5 and 8 mg/kg and fed to the1.0 × 105 CFU/ml of Bacillus licheniformis PKBMS16 injected experimentally challenged ornamental goldfish Carassius auratus for twenty days. Phytol treated group significantly (P < 0.01 and P < 0.05) reduced the rate of fish mortality. After the termination of survivability assay the estimation of hemato-biochemical parameters have been performed and revealed the significant recovery of health condition on 20th days post treatment. Therefore, the present study concluded that the low toxicity along with high bioactivity and tolerance by lower vertebrate supports the potential of phytol as a new compound for inducing fish immunity.


Asunto(s)
Acanthaceae/química , Antibacterianos/farmacología , Bacillus licheniformis/efectos de los fármacos , Enfermedades de los Peces/microbiología , Fitol/farmacología , Extractos Vegetales/farmacología , Animales , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Biomarcadores , Enfermedades de los Peces/tratamiento farmacológico , Cromatografía de Gases y Espectrometría de Masas , Inmunomodulación/efectos de los fármacos , Espectroscopía de Resonancia Magnética , Pruebas de Sensibilidad Microbiana , Fitoquímicos/química , Fitoquímicos/aislamiento & purificación , Fitoquímicos/farmacología , Fitol/química , Fitol/aislamiento & purificación , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Espectroscopía Infrarroja por Transformada de Fourier , Pruebas de Toxicidad Aguda
8.
J Biotechnol ; 304: 57-62, 2019 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-31404564

RESUMEN

Poly-gamma-glutamic acid (γ-PGA) is a water-soluble, nontoxic biocompatible polymer, which is extensively used in medicines, foodstuffs, cosmetics, and in water treatment. We previously isolated a novel γ-PGA producing strain Bacillus licheniformis RK14 from soil and developed a hyper-producing mutant strain RK14-46 by an ethyl methanesulfonate (EMS) treatment. In this study, endo-type (pgdS) and exo-type γ-PGA hydrolases (ggt) were disrupted by integrating plasmids into the genomic DNA of B. licheniformis RK14-46 strain. Unexpectedly, we observed strong inhibition of γ-PGA production following deletion of the pgdS gene, suggesting that pgdS is essential for γ-PGA biosynthesis in strain RK14-46, and in its parent strain RK14. In contrast, γ-PGA production increased by the deletion of the ggt gene and reached 39 g/L in the presence of 90 g/L glucose and elevated oxygen supply. Furthermore, γ-PGA from the ggt-disrupted mutant (Δggt) maintained a larger molecular mass throughout the culture period, whereas that from the original RK14-46 strain had degraded after glucose consumption. γ-PGA-containing culture supernatants from Δggt strain showed greater flocculation efficiency in sewage sludge than supernatants from the RK14-46 strain, reflecting greater production of γ-PGA with larger molecular mass by the Δggt strain. This is the first report concerning the deletion of pgdS and ggt genes in B. licheniformis strain and the properties of γ-PGA obtained from the mutant strain.


Asunto(s)
Bacillus licheniformis/crecimiento & desarrollo , Hidrolasas/genética , Ácido Poliglutámico/análogos & derivados , Bacillus licheniformis/efectos de los fármacos , Bacillus licheniformis/aislamiento & purificación , Bacillus licheniformis/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Biodegradación Ambiental , Técnicas de Inactivación de Genes , Glucosa/metabolismo , Hidrolasas/metabolismo , Oxígeno/metabolismo , Ácido Poliglutámico/metabolismo , Microbiología del Suelo , Aguas Residuales/microbiología
9.
Environ Sci Pollut Res Int ; 26(26): 26972-26981, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31309425

RESUMEN

The endophytic bacteria live in close nuptial relationship with the host plant. The stress experienced by the plant is expected to be transferred to the endophytes. Thus, plants thriving at polluted sites are likely to harbor pollutant-degrading endophytes. The present study reports the isolation of phenylurea herbicides assimilating Bacillus sps. from Parthenium weed growing at diuron-contaminated site. The isolated endophytes exhibited plant growth-promoting (PGP) activities. Among five isolated diuron-degrading endophytes, the most efficient isolate Bacillus licheniformis strain SDS12 degraded 85.60 ± 1.36% of 50 ppm diuron to benign form via formation of degradation intermediate 3, 4-dichloroaniline (3,4-DCA). Cell-free supernatant (CFS) obtained after diuron degradation by strain SDS12 supported algal growth comparable with the pond water. The chlorophyll content and photosynthetic efficiency of green algae decreased significantly in the presence of diuron-contaminated water; however, no such change was observed in CFS of strain SDS12, thus, suggesting that strain SDS12 can be applied in aquatic bodies for degrading diuron and reducing diuron toxicity for primary producers. Further, the use of PGP and diuron-degrading bacteria in agriculture fields will not only help in remediating the soil but also support plant growth.


Asunto(s)
Bacillus licheniformis/metabolismo , Chlorophyta/efectos de los fármacos , Diurona/metabolismo , Diurona/toxicidad , Asteraceae/microbiología , Bacillus licheniformis/efectos de los fármacos , Biodegradación Ambiental , Clorofila/metabolismo , Chlorophyta/metabolismo , Endófitos/efectos de los fármacos , Endófitos/metabolismo , Herbicidas/metabolismo , Herbicidas/toxicidad , Contaminantes del Suelo/metabolismo , Contaminantes del Suelo/toxicidad
10.
Mater Sci Eng C Mater Biol Appl ; 102: 96-105, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31147064

RESUMEN

In this article, we have reported the inclusion complex behaviors and their pharmaceutical application of anticancer drug property of Etoposide with ß-cyclodextrin. The inclusion complex is used to improve the poor aqueous solubility of the anticancer drug Etoposide. The aqueous solubility and in-vitro dissolution studies support to the anticancer drug Etoposide with ß-cyclodextrin complex is significantly improves the aqueous solubility. Etoposide:ß-cyclodextrin solid-state complexes were prepared by Physical mixture, kneading and solvent evaporation methods, and were characterized by FT-IR, 1HNMR, XRD, DSC and SEM techniques. In addition, the in-vitro antimicrobial and antibiofilm study of Etoposide drug is a sensible microorganism was significantly increased by an inclusion complexation process. The antibiofilm of anticancer drug Etoposide with ß-cyclodextrin studies have been analyzed by confocal laser scanning microscopy.


Asunto(s)
Antineoplásicos/farmacología , Bacterias/efectos de los fármacos , Etopósido/farmacología , beta-Ciclodextrinas/farmacología , Bacillus licheniformis/efectos de los fármacos , Bacterias/ultraestructura , Biopelículas/efectos de los fármacos , Rastreo Diferencial de Calorimetría , Pruebas de Sensibilidad Microbiana , Espectroscopía de Protones por Resonancia Magnética , Solubilidad , Espectroscopía Infrarroja por Transformada de Fourier , Vibrio parahaemolyticus/efectos de los fármacos , Difracción de Rayos X
11.
Appl Microbiol Biotechnol ; 103(10): 4003-4015, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30923871

RESUMEN

Poly-γ-glutamic acid (γ-PGA) is an extracellularly produced biodegradable polymer, which has been widely used as agricultural fertilizer, mineral fortifier, cosmetic moisturizer, and drug carrier. This study firstly discovered that lichenysin, as a biosurfactant, showed the capability to enhance γ-PGA production in Bacillus licheniformis. The exogenous addition of lichenysin improved the γ-PGA yield up to 17.9% and 21.9%, respectively, in the native strain B. licheniformis WX-02 and the lichenysin-deficient strain B. licheniformis WX02-ΔlchAC. The capability of intracellular biosynthesis of lichenysin was positively correlated with γ-PGA production. The yield of γ-PGA increased by 25.1% in the lichenysin-enhanced strain B. licheniformis WX02-Psrflch and decreased by 12.2% in the lichenysin-deficient strain WX02-ΔlchAC. Analysis of key enzyme activities and gene expression in the TCA cycle, precursor glutamate synthesis, and γ-PGA synthesis pathway revealed that the existence of lichenysin led to increased γ-PGA via shifting the carbon flux in the TCA cycle towards glutamate and γ-PGA biosynthetic pathways, minimizing by-product formation, and facilitating the uptake of extracellular substrates and the polymerization of glutamate to γ-PGA. Insight into the mechanisms of enhanced production of γ-PGA by lichenysin would define the essential parameters involved in γ-PGA biosynthesis and provide the basis for large-scale production of γ-PGA.


Asunto(s)
Bacillus licheniformis/efectos de los fármacos , Bacillus licheniformis/metabolismo , Vías Biosintéticas/efectos de los fármacos , Lipoproteínas/metabolismo , Péptidos Cíclicos/metabolismo , Ácido Poliglutámico/análogos & derivados , Tensoactivos/metabolismo , Carbono/metabolismo , Análisis de Flujos Metabólicos , Ácido Poliglutámico/biosíntesis
12.
PLoS One ; 14(1): e0210363, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30645638

RESUMEN

Whole-genome sequencing and phenotypic testing of 104 strains of Bacillus licheniformis and Bacillus paralicheniformis from a variety of sources and time periods was used to characterize the genetic background and evolution of (putative) antimicrobial resistance mechanisms. Core proteins were identified in draft genomes and a phylogenetic analysis based on single amino acid polymorphisms allowed the species to be separated into two phylogenetically distinct clades with one outlier. Putative antimicrobial resistance genes were identified and mapped. A chromosomal ermD gene was found at the same location in all B. paralichenformis and in 27% of B. licheniformis genomes. Erythromycin resistance correlated very well with the presence of ermD. The putative streptomycin resistance genes, aph and aadK, were found in the chromosome of all strains as adjacent loci. Variations in amino acid sequence did not correlate with streptomycin susceptibility although the species were less susceptible than other Bacillus species. A putative chloramphenicol resistance gene (cat), encoding a novel chloramphenicol acetyltransferase protein was also found in the chromosome of all strains. Strains encoding a truncated CAT protein were sensitive to chloramphenicol. For all four resistance genes, the diversity and genetic context followed the overall phylogenetic relationship. No potentially mobile genetic elements were detected in their vicinity. Moreover, the genes were only distantly related to previously-described cat, aph, aad and erm genes present on mobile genetic elements or in other species. Thus, these genes are suggested to be intrinsic to B. licheniformis and B. paralicheniformis and part of their ancient resistomes. Since there is no evidence supporting horizontal transmission, these genes are not expected to add to the pool of antibiotic resistance elements considered to pose a risk to human or animal health. Whole-genome based phylogenetic and sequence analysis, combined with phenotypic testing, is proposed to be suitable for determining intrinsic resistance and evolutionary relationships.


Asunto(s)
Bacillus licheniformis/efectos de los fármacos , Bacillus licheniformis/genética , Bacillus/efectos de los fármacos , Bacillus/genética , Farmacorresistencia Bacteriana/genética , Genes Bacterianos , Animales , Bacillus/clasificación , Bacillus licheniformis/clasificación , Proteínas Bacterianas/genética , Resistencia al Cloranfenicol/genética , ADN Bacteriano/genética , Eritromicina/farmacología , Evolución Molecular , Transferencia de Gen Horizontal , Genoma Bacteriano , Humanos , Pruebas de Sensibilidad Microbiana , Modelos Genéticos , Tipificación de Secuencias Multilocus , Filogenia , Estreptomicina/farmacología
13.
Int J Biol Macromol ; 121: 142-151, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30291934

RESUMEN

The production of levan by Bacillus licheniformis NS032 in a medium based on sugar beet molasses was studied. High polysaccharide yields were produced by using diluted molasses (100-140 g/L of total sugars) with the addition of commercial sucrose up to 200 g/L of total sugars, as well as K2HPO4. A levan yield of 53.2 g/L was obtained on a medium optimized by response surface methodology, containing 62.6% of sugar originating from molasses, and 4.66 g/L of phosphate, with initial pH value of 7.2. In comparison to the media with 200 and 400 g/L sucrose, in the molasses optimized medium, the observed bacterial growth was faster, while the maximum production of polysaccharide was achieved over a shorter time interval (48 h). The polysaccharide produced in molasses medium had a weight average molecular weight of 5.82 × 106 Da, degree of branching 12.68%, viscosity of 0.24 dL/g, and based on methylation analysis and NMR data, it did not significantly differ from levan obtained in the medium with 200 g/L sucrose.


Asunto(s)
Bacillus licheniformis/metabolismo , Beta vulgaris/química , Medios de Cultivo/química , Fructanos/biosíntesis , Melaza/análisis , Bacillus licheniformis/efectos de los fármacos , Bacillus licheniformis/crecimiento & desarrollo , Relación Dosis-Respuesta a Droga , Fermentación/efectos de los fármacos , Fructanos/química , Cinética , Peso Molecular , Sacarosa/farmacología , Viscosidad
14.
Environ Sci Pollut Res Int ; 25(23): 22334-22339, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28699006

RESUMEN

A large number of rare earth element mining and application resulted in a series of problems of soil and water pollution. Environmental remediation of these REE-contaminated sites has become a top priority. This paper explores the use of Bacillus licheniformis to adsorb lanthanum and subsequent mineralization process in contaminated water. The maximum adsorption capacity of lanthanum on bacteria was 113.98 mg/g (dry weight) biomass. X-ray diffraction (XRD) and transmission electron microscopy (TEM) data indicated that adsorbed lanthanum on bacterial cell surface occurred in an amorphous form at the initial stage. Scanning electron microscopy with X-ray energy-dispersive spectroscopy (SEM/EDS) results indicated that lanthanum adsorption was correlated with phosphate. The amorphous material was converted into scorpion-like monazite (LaPO4 nanoparticles) in a month. The above results provide a method of using bacterial surface as adsorption and nucleation sites to treat REE-contaminated water.


Asunto(s)
Bacillus licheniformis/metabolismo , Lantano/farmacocinética , Adsorción , Bacillus licheniformis/efectos de los fármacos , Biotransformación , Lantano/química , Metales de Tierras Raras , Microscopía Electrónica de Rastreo , Microscopía Electrónica de Transmisión , Fosfatos/química , Fosfatos/metabolismo , Difracción de Rayos X
15.
An Acad Bras Cienc ; 89(3 Suppl): 2359-2370, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29044330

RESUMEN

During composting processes, the degradation of organic waste is accomplished and driven by a succession of microbial populations exhibiting a broad range of functional competencies. A total of 183 bacteria, isolated from a composting process, were evaluated for cellulase activity at different temperatures (37, 50, 60, and 70°C) and pH values. Out of the 22 isolates that showed activity, isolate 380 showed the highest cellulase activity. Its ability to produce cellulase was evaluated in culture medium supplemented with carboxymethyl cellulose, microcrystalline cellulose, wheat straw, and rice husk. The culture medium supplemented with carboxymethyl cellulose induced higher enzyme activity after 6 hours of incubation (0.12 UEA mL-1 min-1). For wheat straw and rice husk, the results were 0.08 UEA mL-1 min-1 for both, while for microcrystalline cellulose, 0.04 UEA mL-1 min-1 were observed. The highest carboxymethyl cellulase activity was observed at 60°C (0.14 UEA mL-1 min-1) for both crude and partially purified enzyme after 30 and 120 min of incubation, respectively. Alkalinization of the medium was observed during cultivation in all substrates. The cellulase had a molecular mass of 20 kDa determined by SDS-Page. Isolate 380 was identified as Bacillus licheniformis. This work provides a basis for further studies on composting optimization.


Asunto(s)
Bacillus licheniformis/enzimología , Carboximetilcelulosa de Sodio/farmacología , Celulasa/biosíntesis , Celulasa/aislamiento & purificación , Medios de Cultivo/farmacología , Bacillus licheniformis/efectos de los fármacos , Electroforesis en Gel de Poliacrilamida , Calor , Especificidad por Sustrato
16.
Appl Microbiol Biotechnol ; 101(16): 6375-6383, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28601894

RESUMEN

Lichenysin is categorized into the family of lipopeptide biosurfactants and has a variety of applications in the petroleum industry, bioremediation, pharmaceuticals, and the food industry. Currently, large-scale production is limited due to the low yield. This study found that lichenysin production was repressed by supplementation of extracellular amino acids. The global transcriptional factor CodY was hypothesized to prevent lichenysin biosynthesis under an amino acid-rich condition in Bacillus licheniformis. Thus, the codY null strain was constructed, and lichenysin production was increased by 31.0% to 2356 mg/L with the addition of precursor amino acids, and the lichenysin production efficiency was improved by 42.8% to 98.2 mg/L• h. Correspondingly, the transcription levels of the lichenysin synthetase gene lchAA, and its corresponding regulator genes comA, degQ, and degU, were upregulated. Also, the codY deletion enhanced biosynthesis of lichenysin precursor amino acids (Gln, Ile, Leu, and Val) and reduced the formation of byproducts, acetate, acetoin, and 2,3-butanediol. This study firstly reported that lichenysin biosynthesis was negatively regulated by CodY and lichenysin production could be further improved with the precursor amino acid amendment in the codY null strain.


Asunto(s)
Aminoácidos/farmacología , Bacillus licheniformis/efectos de los fármacos , Bacillus licheniformis/metabolismo , Lipoproteínas/biosíntesis , Péptidos Cíclicos/biosíntesis , Factores de Transcripción/deficiencia , Bacillus licheniformis/genética , Proteínas Bacterianas/genética , Proteínas de Unión al ADN/genética , Regulación Bacteriana de la Expresión Génica , Ligasas/genética , Transactivadores/genética , Factores de Transcripción/genética
17.
Artículo en Inglés | MEDLINE | ID: mdl-28368692

RESUMEN

The aim of this study was to ascertain the survival limit and capability of commonly found wastewater protozoan (Aspidisca sp, Trachelophyllum sp and Peranema sp) and bacterial (Bacillus licheniformis, Brevibacillus laterosporus and Pseudomonas putida) species to remove COD while exposed to commercial nanomaterials under varying pH conditions. The experimental study was carried out in modified mixed liquor media adjusted to various pH levels (pH 2, 7 and 10) and a comparative study was performed to determine the difference between the cytotoxicity effects of commercial zinc oxide (nZnO) and silver (nAg) nanomaterials (NMs) on the target wastewater microbial communities using standard methods. The selected microbial communities were exposed to lethal concentrations ranging from 0.015 g/L to 40 g/L for nZnO and from 0.015 g/L to 2 g/L for nAg for a period of 5 days of incubation at 30°C (100 r/min). Compared with the absence of NMs in wastewater mixed liquor, the relevant environmental concentration ranging between 10 µg/L and 100 µg/L, for both nZnO and nAg caused no adverse effects, but the presence of 20 g of nZnO/L and 0.65 g of nAg/L significantly inhibited microbial growth. Statistical evidence showed that nAg was significantly more toxic compared to nZnO, but there was an insignificant difference in toxicity between microbial communities and pH variations. A significant decrease in the removal of COD by microbial populations was observed in the presence of NMs with a moderate correlation of r = 0.3 to r = 0.7 at all pH levels. It was evident that there was a physical interaction between commercial NMs and target wastewater microbial communities; although not quantitatively assessed, cell morphology and cell death were observed. Such phenomena suggest the high resilience of the microbial community, but it is the accumulation of NMs that will have adverse effects on the performance in terms of COD removal.


Asunto(s)
Consorcios Microbianos/efectos de los fármacos , Nanoestructuras/toxicidad , Plata/toxicidad , Aguas Residuales/microbiología , Contaminantes Químicos del Agua/toxicidad , Óxido de Zinc/toxicidad , Bacillus licheniformis/efectos de los fármacos , Análisis de la Demanda Biológica de Oxígeno , Brevibacillus/efectos de los fármacos , Cilióforos/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Concentración de Iones de Hidrógeno , Nanoestructuras/química , Pseudomonas putida/efectos de los fármacos , Plata/química , Contaminantes Químicos del Agua/química , Purificación del Agua , Óxido de Zinc/química
18.
J Basic Microbiol ; 57(5): 364-375, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28156000

RESUMEN

Industrial biofouling-problems associated with the accumulation of microorganisms from flowing water and fluids on processing surfaces can cause severe problems. A Pseudomonas aeruginosa strain W10 was isolated from industrial setting and found to produce predominantly di-rhamnolipids (Rha-Rha-C10-C10) with a yield of around 10 g L-1 and a critical micelle concentration (CMC) of 80 mg L-1 . P. aeruginosa W10 rhamnolipids were able to disrupt up to 99% of 48 h pre-formed biofilms of the Gram-positive organisms Bacillus licheniformis CAN55, Staphylococcus capitis SH6, and a mixed culture (strains CAN55, SH6, and W10), under static conditions, at concentrations of 0.1, 0.5, and 1 mg ml-1 on a stainless steel surface commonly used in industrial process pipelines. CFU measurements and LIVE/DEAD BacLight staining confirmed these observations. Furthermore, a purified di-rhamnolipid fraction was found to be responsible for the microbial inhibition of B. licheniformis strain CAN55. This study provides evidence that rhamnolipids may have valuable applications in preventing biofilms and biofouling in industrial plants and, in a wider context, may also apply to metal medical devices.


Asunto(s)
Biopelículas/efectos de los fármacos , Incrustaciones Biológicas/prevención & control , Glucolípidos/farmacología , Metales/química , Pseudomonas aeruginosa/metabolismo , Antiinfecciosos/farmacología , Bacillus licheniformis/efectos de los fármacos , Bacillus licheniformis/fisiología , Glucolípidos/química , Microbiología Industrial , Pruebas de Sensibilidad Microbiana , Viabilidad Microbiana/efectos de los fármacos , Pseudomonas aeruginosa/química , Staphylococcus/efectos de los fármacos , Staphylococcus/fisiología , Tensoactivos/química , Tensoactivos/farmacología
19.
An. acad. bras. ciênc ; 89(3,supl): 2359-2370, 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-886801

RESUMEN

ABSTRACT During composting processes, the degradation of organic waste is accomplished and driven by a succession of microbial populations exhibiting a broad range of functional competencies. A total of 183 bacteria, isolated from a composting process, were evaluated for cellulase activity at different temperatures (37, 50, 60, and 70°C) and pH values. Out of the 22 isolates that showed activity, isolate 380 showed the highest cellulase activity. Its ability to produce cellulase was evaluated in culture medium supplemented with carboxymethyl cellulose, microcrystalline cellulose, wheat straw, and rice husk. The culture medium supplemented with carboxymethyl cellulose induced higher enzyme activity after 6 hours of incubation (0.12 UEA mL-1 min-1). For wheat straw and rice husk, the results were 0.08 UEA mL-1 min-1 for both, while for microcrystalline cellulose, 0.04 UEA mL-1 min-1 were observed. The highest carboxymethyl cellulase activity was observed at 60°C (0.14 UEA mL-1 min-1) for both crude and partially purified enzyme after 30 and 120 min of incubation, respectively. Alkalinization of the medium was observed during cultivation in all substrates. The cellulase had a molecular mass of 20 kDa determined by SDS-Page. Isolate 380 was identified as Bacillus licheniformis. This work provides a basis for further studies on composting optimization.


Asunto(s)
Carboximetilcelulosa de Sodio/farmacología , Celulasa/aislamiento & purificación , Celulasa/biosíntesis , Medios de Cultivo/farmacología , Bacillus licheniformis/enzimología , Especificidad por Sustrato , Electroforesis en Gel de Poliacrilamida , Bacillus licheniformis/efectos de los fármacos , Calor
20.
PLoS One ; 11(11): e0166796, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27898684

RESUMEN

The degradation efficiency of organic contaminants and their associated metabolites by co-culture of microbes is mainly limited by toxic intermediates from co-metabolic degradation. In this study, we investigated the degradation of ß-cypermethrin (ß-CY) and 3-phenoxybenzoic acid (3-PBA) by co-culture of Bacillus licheniformis B-1 and Aspergillus oryzae M-4, as well as the influences of ß-CY and 3-PBA metabolites on their degradation and the growth of strains B-1 and M-4. Our results indicated that 100 mg/L ß-CY was degraded by 78.85%, and 3-PBA concentration was 0.05 mg/L after 72 h. Compared with using only strain B-1, the half-life (t1/2) of ß-CY by using the two strains together was shortened from 84.53 h to 38.54 h, and the yield coefficient of 3-PBA was decreased from 0.846 to 0.001. At 100 mg/L of 3-PBA and gallic acid, ß-CY and 3-PBA degradation were only 17.68% and 40.45%, respectively. As the toxic intermediate derived from co-metabolic degradation of ß-CY by strain B-1, 3-PBA was efficiently degraded by strain M-4, and gallic acid, as the toxic intermediate from co-metabolic degradation of 3-PBA by strain M-4, was efficiently degraded by strain B-1. These results provided a promising approach for efficient biodegradation of ß-CY and 3-PBA.


Asunto(s)
Aspergillus oryzae/metabolismo , Bacillus licheniformis/metabolismo , Benzoatos/metabolismo , Piretrinas/metabolismo , Aspergillus oryzae/efectos de los fármacos , Aspergillus oryzae/crecimiento & desarrollo , Bacillus licheniformis/efectos de los fármacos , Bacillus licheniformis/crecimiento & desarrollo , Benzoatos/farmacología , Técnicas de Cocultivo , Piretrinas/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...